Current data and strategy in glioblastoma multiforme, J Med Life, vol.2, issue.4, pp.386-93, 2009. ,
The epidemiology of glioma in adults: a "state of the science, review. Neuro Oncol, vol.16, issue.7, pp.896-913, 2014. ,
,
, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-96, 2005.
, ?lng=EN&data_id=3752&Disease_Disease_Search_diseaseGroup=gl ioblastome&Disease_Disease_Search_diseaseType=Pat&Maladie(s)/groupes%20de%20mala dies=Glioblastome&title=Glioblastome&search=Disease_Search_Simple, 2007.
Epidemiology of brain tumors, Neurol Clin, vol.25, issue.4, pp.867-90, 2007. ,
Highgrade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ,
, Ann Oncol, vol.25, issue.3, pp.93-101, 2014.
How does photodynamic therapy work?, Photochem Photobiol, vol.55, issue.1, pp.145-57, 1992. ,
Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes, Journal of photochemistry and photobiology B, Biology, vol.58, issue.2-3, pp.149-55, 2000. ,
Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon, Photochemistry and photobiology, vol.69, issue.1, pp.71-77, 1999. ,
Interstitial photodynamic therapy and glioblastoma: Light fractionation in a preclinical model. Lasers in surgery and medicine, vol.49, pp.506-521, 2017. ,
Light Dose Fractionation to Enhance Photodynamic Therapy With 5-Aminolevulinic Acid in Human glioma xenografts, The International Congress on Photodynamic Applications, 2014. ,
,
MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model. Lasers in surgery and medicine, vol.50, pp.460-468, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01616405
Determination of fluence rate and temperature distributions in the rat brain; implications for photodynamic therapy, Journal of biomedical optics, vol.12, issue.1, p.14003, 2007. ,
Fluence rate as a modulator of PDT mechanisms. Lasers in surgery and medicine, vol.38, pp.489-93, 2006. ,
Molecular mechanisms associated with ALAPDT of brain tumor cells2009 ,
Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue, British journal of cancer, vol.83, issue.8, pp.1110-1117, 2000. ,
Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors, Photochemistry and photobiology, vol.80, pp.22-30, 2004. ,
Photodynamic therapy of human glioma (U87) in the nude rat, Photochemistry and photobiology, vol.64, issue.4, pp.707-718, 1996. ,
,
, Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results, Photodiagnosis Photodyn Ther, vol.13, pp.218-242, 2016.
Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid, J Neurosurg, vol.97, issue.4, pp.970-976, 2002. ,
,
, Radiologe, vol.35, issue.12, pp.894-901, 1995.
Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling, NMR in biomedicine, vol.10, issue.4-5, pp.237-286, 1997. ,
Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy, Br J Cancer, vol.104, issue.5, pp.798-807, 2011. ,
,
, INtraoperative photoDYnamic Therapy for GliOblastomas: Study Protocol for a Phase I Clinical Trial, 2018.